MONTREAL, August 8 /CNW/ - Genizon BioSciences today announced a license and collaboration agreement with Genentech, Inc. (NYSE:DNA) of South San Francisco, Calif. Genizon grants Genentech an exclusive license to Genizon’s GeneMap of disease-associated genes generated from a whole genome association study of Crohn’s disease patients from the Quebec Founder Population.
